Nassim Usman
Board Member
Gyre Therapeutics, Inc. (GYRE)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-12-26–present
-
Current
-
Start not stated–2024-06-30
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Gyre Therapeutics, Inc. (GYRE) | President and Chief Executive Officer Clinton ^^ Musil Chief Financial Officer | $574,244 | $1,409,622 |
| 2019 | Gyre Therapeutics, Inc. (GYRE) | President and Chief Executive Officer Clinton ^^ Musil Chief Financial Officer | $524,832 | $1,198,865 |
| 2018 | Gyre Therapeutics, Inc. (GYRE) | President and Chief Executive Officer | $480,800 | $2,442,314 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.